|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Endocrinology and Metabolism |
1 Department of Pediatrics, Friedrich-Alexander-University, Erlangen, Germany.
aAddress correspondence to this author at: Department of Pediatrics, Friedrich-Alexander-University, Erlangen, Loschgestr. 15, 91054 Erlangen, Germany. Fax 49-9131-8533714; e-mail manfred.rauh{at}kinder.imed.uni-erlangen.de.
Background: A sensitive method specific for ghrelins is needed for investigations of this gastrointestinal peptide. Our aim was to develop and validate a quantitative mass spectrometry (MS) method to measure ghrelin and desacyl-ghrelin simultaneously.
Methods: After deproteinization by precipitation, we performed reversed-phase separation with a rapid 2-column online extraction design coupled to a quadrupole mass spectrometer for electrospray ionization MS detection. Chromatography was performed on a C18 monolithic column, with ammonium acetate buffer/methanol as the mobile phase and a chromatographic run time of 6 min/sample. The 4-foldcharged ions were used for multiple reaction monitoring experiments.
Results: The method was linear with injections of 0.0110 ng. Limits of detection and quantification were 0.02 and 0.07 µg/L for ghrelin, respectively, and 0.03 and 0.35 µg/L for desacyl-ghrelin. Intra- and interday imprecision (CVs) were 9%4% and 12%6% at concentrations of 0.335.93 µg/L for ghrelin, respectively, and 16%6% and 15%8% at concentrations of 1.1210.02 µg/L for desacyl-ghrelin. The mean (SD) recoveries in plasma of added ghrelin and desacyl-ghrelin were 95.8% (12%) and 101% (1.2%), respectively. Using kinetic modeling, we determined the mean (SD) periods of half-change (t1/2) of ghrelin to be 156 (16) min in EDTA plasma and 49 (1) min in Li-heparin plasma. BlandAltman analysis showed that the median differences between EIA and liquid chromatographytandem mass spectrometry (MS/MS) for desacyl-ghrelin were 40% for plasma/serum samples and 85% for cell supernatants and for ghrelin were 6% for enriched plasma samples and 44% for cell supernatants.
Conclusion: Our HPLC-MS/MS procedure has excellent selectivity and sufficient limit of quantification to allow the monitoring of concentrationtime profiles in biological matrices.
The following articles in journals at HighWire Press have cited this article:
![]() |
M. Groschl Current Status of Salivary Hormone Analysis Clin. Chem., November 1, 2008; 54(11): 1759 - 1769. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |